Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma
Med Clin (Barc). 2023 Dec 2:S0025-7753(23)00673-5. doi: 10.1016/j.medcli.2023.11.003. Online ahead of print.NO ABSTRACTPMID:38044186 | DOI:10.1016/j.medcli.2023.11.003
Source: Medicina Clinica - Category: General Medicine Authors: Thais Lizondo L ópez Iria Carro M éndez Esther Carcelero San Mart ín Source Type: research
More News: Cancer & Oncology | Carcinoma | General Medicine | Hepatocellular Carcinoma | Liver Cancer | Myocarditis